While T cell- redirecting BsAbs like ERY974 (GPC3/CD3) are under clinical evaluation, their reliance on T cells limits efficacy in the immunosuppressive HCC microenvironment. This evidence concerns the gene GPC3 and hepatocellular carcinoma.